Search Results 1221-1230 of 1988 for Immunode

1. Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors - Mayo Clinic

   ... immunodeficiency virus (HIV) positivity are allowed if CD4 count > 500 cells/uL. No known active or uncontrolled infections requiring ongoing antifungals or ...

2. A Study Comparing Orteronel Plus Prednisone in Patients with Metastatic Castration-Resistant Prostate Cancer, who have not had Chemotherapy - Mayo Clinic

   Known history of human immunodeficiency virus (HIV) infection, hepatitis B, or hepatitis C; Unwilling or unable to comply with protocol; Uncontrolled nausea ...

3. Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer - Mayo Clinic

   - Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for ...

4. Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year - Mayo Clinic

   Is infected with human immunodeficiency virus (HIV; positive serology for HIV antibody). Has a concomitant diagnosis or any history of congestive heart ...

5. Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission - Mayo Clinic

   No known Human Immunodeficiency Virus (HIV) seropositivity. The risk for potential toxicities secondary to HIV (e.g., increased risk for fatal opportunistic ...

6. A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of Chronic Spontaneous Urticaria in Adults Inadequately Controlled by H1-antihistamines - Mayo Clinic

   immunodeficiency that, in the investigator's opinion, would compromise the safety of the participant, interfere with the interpretation of the study results ...

7. A Study Of NT-112 In HLA-C*08:02-Positive Adult Subjects With Unresectable, Advanced, And/ Or Metastatic Solid Tumors Positive For The KRAS G12D Mutation - Mayo Clinic

   Any form of primary immunodeficiency. Active immune-mediated disease requiring systemic steroids or other immunosuppressive treatment (except if related to ...

8. Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) - Mayo Clinic

   Has known human immunodeficiency virus (HIV) seropositive. Has known hepatitis B surface antigen seropositive, or known or suspected active hepatitis C ...

9. Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors - Mayo Clinic

   Known human immunodeficiency virus (HIV) patients with active and untreated disease. Central nervous system (CNS) involvement unless they meet ALL of the ...

10. Study to Evaluate Chemoembolization Combined with Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma - Mayo Clinic

    ... immunodeficiency virus (positive HIV 1/2 antibodies). Patients co-infected with HBV and hepatitis D virus (HDV). (HBV infection is indicated by the presence ...